Compare OWLS & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OWLS | CERS |
|---|---|---|
| Founded | 2010 | 1991 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.9M | 501.8M |
| IPO Year | 2024 | 1996 |
| Metric | OWLS | CERS |
|---|---|---|
| Price | $5.46 | $2.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | 26.8K | ★ 1.2M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $51,326,000.00 |
| Revenue This Year | $6.57 | $19.95 |
| Revenue Next Year | $375.69 | $8.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 30.68 |
| 52 Week Low | $4.77 | $1.20 |
| 52 Week High | $29.00 | $3.47 |
| Indicator | OWLS | CERS |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 42.94 |
| Support Level | $5.25 | $2.37 |
| Resistance Level | $5.66 | $2.68 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 87.49 | 22.06 |
OBOOK Holdings Inc operate as a blockchain-powered technology company. It provides solutions across three main business segments: payments, hospitality, and e-commerce, serving businesses and individuals whose commercial activities involve cross-border transactions. The company has five reportable segments: Payment service provides payment solutions to customers, including payment gateway services and payout services; Hospitality-related software services provide the subscription to the OwlNest PMS and the add-on room fee collection services offered to the clients using OwlNest; Hospitality-related platform services that provide an OTA platform and offline platform services offering accommodation services; The E-commerce platform engages in selling products online; and Other services.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.